Psychological well-being in advanced NSCLC patients in Serbia: Impact of sociodemographic and clinical factors

Neoplasma

Volumn 57, Issue 1, 2010, Pages 1-7

  Maric, D M ^a   Jovanovic, D M ^a   Golubicic, I V ^b   Nagorni Obradovic, L J M ^a   Stojsic, J M ^a   Pekmezovic, T D ^c  

^a CLINICAL CENTER OF SERBIA   (Serbia)

^b INSTITUTE FOR ONCOLOGY AND RADIOLOGY OF SERBIA   (Serbia)

^c UNIVERSITY OF BELGRADE   (Serbia)

Author keywords

Anxiety; Chemotherapy; Chemotherapy induced nausea and vomiting; Depression; Lung cancer; Quality of life

Indexed keywords

CARBOPLATIN; CISPLATIN; ETOPOSIDE; GEMCITABINE; ANTINEOPLASTIC AGENT;

ADULT; ADVANCED CANCER; AGED; ANXIETY; ARTICLE; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER STAGING; CLINICAL ASSESSMENT; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DEMOGRAPHY; DEPRESSION; EMOTION; FEMALE; HAMILTON ANXIETY SCALE; HAMILTON SCALE; HUMAN; INFORMATION PROCESSING; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MENTAL FUNCTION; NAUSEA AND VOMITING; PSYCHOLOGICAL WELL BEING; QUALITY OF LIFE; SERBIA; SOCIOECONOMICS; SYMPTOM; AGE; LUNG TUMOR; MIDDLE AGED; PSYCHOLOGICAL ASPECT; SEX DIFFERENCE;

AGE FACTORS; AGED; ANTINEOPLASTIC AGENTS; ANXIETY; CARCINOMA, NON-SMALL-CELL LUNG; CROSS-SECTIONAL STUDIES; DEPRESSION; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; QUALITY OF LIFE; SERBIA; SEX FACTORS;

EID: 77953634260     PISSN: 00282685     EISSN: None     Source Type: Journal    
DOI: 10.4149/neo_2010_01_001     Document Type: Article

References (49)

1. RYAN H, SCHOFIELD P, COCKBURN J, BUTOW P, TATTERSALL M, et al. How to recognize and manage psychological distress in cancer patients. Eur J Cancer Care 2005; 14: 7-15. doi:10.1111/j.1365-2354.2005.00482.x
2. HANN D, WINTER K, JACOBSEN P. Measurement of depressive symptoms in cancer patients: evaluation of the Center for Epidemiological Studies Depression Scale (CES-D). J Psichosom Res 1999; 46 (5): 437-443.
3. MASSIE MJ, HOLLAND JC. Depression and the cancer patients. J Clin Psychiatry 1990; 75: 12-17.
4. KAASA S, MALT U, HAGEN S, WIST E, MORUM T, KVIKSTAD A. Psychological distress in cancer patients with advanced disease. Radiother Oncol 1993; 27: 193-197. doi:10.1016/0167-8140(93)90073-H
5. PLUMB M, HOLLAND JC. Comparative studies of psychological function in patients with advanced cancer: Self-reported depressive symptoms. Psychosom Med 1977; 39: 264-276.
6. DEROGATIS LR, MORROW GR, FETTING J, PENMAN D, PIASETSKY S, et al. The prevalence of psychiatric disorder among cancer patients. JAMA 1983; 249: 751-757. doi:10.1001/jama.249.6.751
7. HOPWOOD P, STEPHENSEN RJ. Depression in patients with lung cancer: prevalence and risk factor derived from quality of life data. J Clin Oncol 2000; 18: 893-903.
8. DEVITA VTJ, HELLMAN S, ROSENBERG SA. Cancer principles and practice of oncology. 7th edition. Philadelphia, PA: Lippincott-Raven, 2004.
9. Non-Small cell Lung Cancer Collaborative Group. Chemotherapy in non-small cell lung cancer: a meta analysis using updated data on individual patients from 52 randomised clinical trials. British Medical Journal 1995; 311: 899-909.
10. ZABORA J, BRINTZENHOFESZOC K, CURBOW B, HOOKER C, PIANTADOSI S. The prevalence of psychological distress by cancer site. Psycho Oncology 2001; 10: 19-28. doi:10.1002/1099-1611(200101/02)10:1<19::AIDPON501> 3.0.CO;2-6
11. GINSBURG M, QUIRT C, GINSBURG A, MACKILLOP W. Psychiatric illness and psychosocial concerns of patients with newly diagnosed lung cancer. Can Med Assoc J 1995, 152: 1961-1963.
12. MONTAZERI A, MILROY R, HOLE D, MCEWEN J, GILLIS CR. Anxiety and depression in patients with lung cancer before and after diagnosis: findings from population in Glasgow, Scotland. J Epidemiol Community Health 1998; 52: 203-204. doi:10.1136/jech.52.3.203
13. BUCCHERI G. Depressive reactions to lung cancer are common and often followed by a poor outcome. Eur Respir J 1998; 11: 173-178. doi:10.1183/09031936.98.11010173
14. LLOYD-WILLIAMS M, DENNIS M, TAYLOR F. A prospective study to determine the association between physical symptoms and depression in patients with advanced cancer. Palliate Med 2004; 18: 558-563. doi:10.1191/0269216304pm923oa
15. STIEFEL R, DIE TM, BERNEY A, OLARTE JM, RAZAVI A. Depression in palliative care: a pragmatic repor from the Expert Working Group of the European Association for Palliative Care. Support Care Cancer 2001; 9: 477-488. doi:10.1007/s005200100244
16. LLOYD-WILLIAMS M, REEVE J, KISSANE D. Distress in palliative care patients: Developing patient-centred approaches to clinical management. Eur J Cancer 2008; 44: 1133-1138. doi:10.1016/j.ejca.2008.02.032
17. LLOYD-WILLIAMS M. Diagnosis and treatment of depression in palliative care. Eur J Palliat Care 2002; 9: 186-189.
18. BOWERS L, BOYLE DA. Depression in patients with advanced cancer. Clin J Oncol Nurs 2003; 7: 281-288. doi:10.1188/03. CJON.281-288
19. LLOYD-WILLIAMS M, SHEILS C, TAYLOR F, DENNIS M. Depression an independent risk factor for early mortality in patients with advanced cancer. J Affect Disord (in press).
20. MCCABEW MP, DE JUDICIBUS M. The effects of economic disadvantage on psychological well-being and quality of life among people with multiple sclerosis. J Health Psychol 2005; 10: 163-73. doi:10.1177/1359105305048562
21. EDELSTEIN B. Comprehensive Clinical Psychology Volume 7: Clinical Geropsychology. Amsterdam: Elsevier, 1998.
22. MARUISH MR. The Use of Psychological Testing for Treatment Planning and Outcomes Assessment. Mahwah, NJ: Lawrence Erlbaum Associates, 1999.
23. SF-36 Health Survey (Original version) Language Recalls. Retrived January 10, 2007 from http://www.qualitymetric.com
24. The EORTC Quality Of Life Study Group and EORTC Quality Of Life Unit. Guidelines for assessing quality of life in EORTC clinical trials. EORTC Quality Of Life Study Group, Brussels 1999.
25. MARIC D, JOVANOVIC D, GOLUBICIC I, DIMIC S, PEKMEZOVIC T. Health-related quality of life in lung cancer patients in Serbia: correlation with socioeconomic and clinical factors. Eur J Cancer Care 2009, in press.
26. AKECHI T, KUGAYA A, OKAMURA H, NISHIWAKI, Y, YAMAWAKI, S, UCHITOMI, Y. Predictive factors for psycho logical distress in ambulatory lung cancer patients. Support Care Cancer 1998; 6: 281-286. doi:10.1007/s005200050167
27. JAKOBSEN PB, DONOVAN KA, TRASK PC, FLEISHMAN SB, ZABORA J, et al. Screening for psychological distress in ambulatory cancer patients: a multicenter evaluation of the Distress Thermometer. Cancer 2005; 103: 1494-502.
28. GRAVES KD, ARNOLD SM, LOVE CL, KIRSH KL, MOORE PG, PASSIK SD. Distress screening in a multidisciplinary lung cancer clinic: Prevalence and predictors of clinically significant distress. Lung Cancer 2007; 55: 215-224. doi:10.1016/ j.lungcan.2006.10.001
29. AKIZUKI N, AKECHI T, NAKANISHI T, YOSHIKAWA E, OKAMURA M, et al. Development of a brief screening interview for adjustment disorders and major depression in patients with cancer. Cancer 2003; 97: 2605-13. doi:10.1002/ cncr.11358
30. MICHELSON H, BOLUND C, NILSSON B, BRANDBERG Y. Health related quality of life measured by the EORTC QLQ C-30. Reference values from a large sample of the Swedish population. Acta Oncol 2000; 39: 477-84. doi:10.1080/ 028418600750013384
31. LÖVGREN M, TISHELMAN C, SPRANGERS M, KOYIF H, HAMBERGG K. Symptoms and problems with functioning among women and men with inoperable lung cancer-a longitudinal study. Lung Cancer 2008; 60: 113-124. doi:10.1016/j.lungcan.2007.09.015
32. MONTAZERI A, MILROY R, HOLE D, MCEWEN J, GILLIS CR. Quality of life in lung cancer patients as an important prognosis factor. Lung Cancer 2001; 31: 233-240. doi:10.1016/S0169-5002(00)00179-3
33. MOHAN A, MOHAN C, BHUTANI M, PATHAK AK, PAL H, et al. Quality of life in newly diagnosed patients with lung cancer in developing country: is it important? Eur J Cancer Care 2006, 15, 293-298. doi:10.1111/j.1365-2354.2006.00654.x
34. BROWN S, THORPE H, NAPP V, BROWN J. Closeness to death and quality of life in advanced lung cancer patients. Clinical Oncology 2007, 19, 341-348. doi:10.1016/ j.clon.2007.02.008
35. SIDORCHUK A, AGARDH EE, AREMU O, HALLQVIST J, ALLEBECK P, MORADI T. Socioeconomic differences in lung cancer incidence: a systematic review and meta-analysis. Cancer Causes Control 2009, in press. doi:10.1007/s10552-009-9300-8
36. SARNA L. Women with lung cancer: Impact on quality of life. Qual Life Res 1993; 2: 13-22. doi:10.1007/BF00642885
37. PENSON DF, STODDARD ML, PASTA DJ, LUBECK DP, FLANDERS SC, LITWIN MS. The association between socioeconomic status, health insurance coverage, and quality of life in men with prostate cancer. J Clin Epidemiol 2001; 54: 350-358. doi:10.1016/S0895-4356(00)00312-7
38. UCHITOMI Y, MIKAMI I, NAGAI K, NISHIWAKI Y, AKECHI T, OKAMURA H. Depression and psychological distress in patients during the year after curative resection of non-small cell lung cancer. J Clin Oncol 2003; 21: 69-77. doi:10.1200/JCO.2003.12.139
39. BARBARESCHI G, SANDERMAN R, TUINSTRA J, VAN SONDEREN E, RANCHOR, AV. A prospective study of educational level and adaptation to cancer, within one year after the diagnosis, in an older population. Psychooncology 2008; 17: 373-382. doi:10.1002/pon.1243
40. LITWIN MS, MCGUIGAN KA, SHPALL AI, DHANANI N. Recoveri of health-related quality of life in the year after radical prostatectomy: early experience. The journal of urology 1999; 161: 515-519. doi:10.1016/S0022-5347(01)61938-4
41. SIMON EA, WARDLE J. Socioeconomic disparities in psychosocial wellbeing in cancer patients. Eur J Cancer 2008, 44; 572-578. doi:10.1016/j.ejca.2007.12.013
42. MONTAZERI A, HOLE DJ, MILROY R, MCEWEN J, GILLIS CR. Quality of life in lung cancer patients: does socioeconomic status matter? Health and Quality of Life Outcomes 2003; 1: 19. doi:10.1186/1477-7525-1-19
43. THONGPRASERT S, SANUGANMITRA P, JUTHAPAN N, CLINCH J. Relationship between quality of life and clinical outcomes in advanced non-small cell lung cancer: best supportive care (BSC) vs. BSC plus chemotherapy. Lung Cancer 1999; 24: 17-25. doi:10.1016/S0169-5002(99)00017-3
44. BELANI CP, PEREIRA JR, VON PAWEL J, PLUZANSKA A, GORBOUNOVA V, et al. Effect of chemotherapy for advanced non-small cell lung cancer on patient's quality of life. A randomised controlled trial. Lung Cancer 2006; 53: 231-239. doi:10.1016/j.lungcan.2006.05.003
45. HICKOK JT, ROSCOE JA, MORROW GR, KING DK, ATKINS JN, FITCH TR. Nausea and emesis remain significant problems of chemotherapy despite prophylaxis with 5-hidroxytryptamine-3 antiemetics: a University of Rochester James P. Wilmot Cancer Center Community Clinical Oncology Program Study of 360 cancer patients treated in community. Cancer 2003; 97: 2880-2886. doi:10.1002/cncr.11408
46. HESKETH PJ. Chemotherapy-induced nausea and vomiting. N Engl J Med 2008; 358: 2482-2494. doi:10.1056/ NEJMra0706547
47. LINDELY CM, HIRSH JD, O'NEILL CV, TRANSAU MC, GILBERT CS, OSTERHAUS JT. Quality of life consequences of chemotherapy induced emesis. Qual Life Res 1992; 1: 331-340. doi:10.1007/BF00434947
48. MARTIN CG, RUBENSTEIN EB, ELTING LS, KIM YJ, OSOBA D. Measuring chemotherapy-induced nausea and emesis. Cancer 2003; 98; 645-655. doi:10.1002/cncr.11540
49. MORITA S, KOBAYASHI K, EGUCHI K, MATSUMOTO T, SHIBUYA M, et al. Influence of clinical parameters on quality of life during chemotherapy in patients with advanced nonsmall cell lung cancer: application of a general linear model. Jpn J Clin Oncol 2003; 33(9): 470-476. doi:10.1093/jjco/ hyg083